As dermatological treatments move up the ranking of conditions with the highest paid drug claims, they’ve become increasingly significant for private drug plan sponsors, according to Frances Lehun, a pharmacist with pharmaceutical expertise in high-cost drug management at Beneva. During a session at the 2025 Face to Face Drug Plan Management Forum, she said this […]
In 2021, more than 50 per cent of people with psoriasis and psoriatic arthritis said their condition has had a negative impact at work, according to Antonella Scali, executive director at the Canadian Psoriasis Network, speaking during a session at the annual Canadian Arthritis Research Conference last week. People living with inflammatory conditions often report […]